In a study published in the journal Nature Reviews Drug Discovery last week, a group of Harvard Medical School researchers found that early trials of certain central nervous system drugs weren’t very predictive of whether the drugs ultimately worked. Aaron Kesselheim (Brigham and Women’s) led the research.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure